Literature DB >> 31769740

Texture Analysis with 3.0-T MRI for Association of Response to Neoadjuvant Chemotherapy in Breast Cancer.

Na Lae Eun1, Daesung Kang1, Eun Ju Son1, Jeong Seon Park1, Ji Hyun Youk1, Jeong-Ah Kim1, Hye Mi Gweon1.   

Abstract

Background Previous studies have suggested that texture analysis is a promising tool in the diagnosis, characterization, and assessment of treatment response in various cancer types. Therefore, application of texture analysis may be helpful for early prediction of pathologic response in breast cancer. Purpose To investigate whether texture analysis of features from MRI is associated with pathologic complete response (pCR) to neoadjuvant chemotherapy (NAC) in breast cancer. Materials and Methods This retrospective study included 136 women (mean age, 47.9 years; range, 31-70 years) who underwent NAC and subsequent surgery for breast cancer between January 2012 and August 2017. Patients were monitored with 3.0-T MRI before (pretreatment) and after (midtreatment) three or four cycles of NAC. Texture analysis was performed at pre- and midtreatment T2-weighted MRI, contrast material-enhanced T1-weighted MRI, diffusion-weighted MRI, and apparent diffusion coefficient (ADC) mapping by using commercial software. A random forest method was applied to build a predictive model for classifying those with pCR with use of texture parameters. Diagnostic performance for predicting pCR was assessed and compared with that of six other machine learning classifiers (adaptive boosting, decision tree, k-nearest neighbor, linear support vector machine, naive Bayes, and linear discriminant analysis) by using the Wald test and DeLong method. Results Forty of the 136 patients (29%) achieved pCR after NAC. In the prediction of pCR, the random forest classifier showed the lowest diagnostic performance with pretreatment ADC (area under the receiver operating characteristic curve [AUC], 0.53; 95% confidence interval: 0.44, 0.61) and the highest diagnostic performance with midtreatment contrast-enhanced T1-weighted MRI (AUC, 0.82; 95% confidence interval: 0.74, 0.88) among pre- and midtreatment T2-weighted MRI, contrast-enhanced T1-weighted MRI, diffusion-weighted MRI, and ADC mapping. Conclusion Texture parameters using a random forest method of contrast-enhanced T1-weighted MRI at midtreatment of neoadjuvant chemotherapy were valuable and associated with pathologic complete response in breast cancer. © RSNA, 2019 Online supplemental material is available for this article.

Entities:  

Mesh:

Year:  2019        PMID: 31769740     DOI: 10.1148/radiol.2019182718

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  22 in total

1.  Texture analysis of MR images to identify the differentiated degree in hepatocellular carcinoma: a retrospective study.

Authors:  Mengmeng Feng; Mengchao Zhang; Yuanqing Liu; Nan Jiang; Qian Meng; Jia Wang; Ziyun Yao; Wenjuan Gan; Hui Dai
Journal:  BMC Cancer       Date:  2020-06-30       Impact factor: 4.430

2.  A radiomics pipeline dedicated to Breast MRI: validation on a multi-scanner phantom study.

Authors:  Marie-Judith Saint Martin; Fanny Orlhac; Pia Akl; Fahad Khalid; Christophe Nioche; Irène Buvat; Caroline Malhaire; Frédérique Frouin
Journal:  MAGMA       Date:  2020-11-12       Impact factor: 2.310

3.  Multi-center evaluation of artificial intelligent imaging and clinical models for predicting neoadjuvant chemotherapy response in breast cancer.

Authors:  Tan Hong Qi; Ong Hiok Hian; Arjunan Muthu Kumaran; Tira J Tan; Tan Ryan Ying Cong; Ghislaine Lee Su-Xin; Elaine Hsuen Lim; Raymond Ng; Ming Chert Richard Yeo; Faye Lynette Lim Wei Tching; Zhang Zewen; Christina Yang Shi Hui; Wong Ru Xin; Su Kai Gideon Ooi; Lester Chee Hao Leong; Su Ming Tan; Madhukumar Preetha; Yirong Sim; Veronique Kiak Mien Tan; Joe Yeong; Wong Fuh Yong; Yiyu Cai; Wen Long Nei
Journal:  Breast Cancer Res Treat       Date:  2022-03-09       Impact factor: 4.872

Review 4.  A review of studies on omitting surgery after neoadjuvant chemotherapy in breast cancer.

Authors:  Kexin Feng; Ziqi Jia; Gang Liu; Zeyu Xing; Jiayi Li; Jiaxin Li; Fei Ren; Jiang Wu; Wenyan Wang; Jie Wang; Jiaqi Liu; Xiang Wang
Journal:  Am J Cancer Res       Date:  2022-08-15       Impact factor: 5.942

5.  MRI-based Texture Analysis of Infrapatellar Fat Pad to Predict Knee Osteoarthritis Incidence.

Authors:  Jia Li; Shuai Fu; Ze Gong; Zhaohua Zhu; Dong Zeng; Peihua Cao; Ting Lin; Tianyu Chen; Xiaoshuai Wang; Richard Lartey; C Kent Kwoh; Ali Guermazi; Frank W Roemer; David J Hunter; Jianhua Ma; Changhai Ding
Journal:  Radiology       Date:  2022-05-31       Impact factor: 29.146

6.  Robustness Evaluation of a Deep Learning Model on Sagittal and Axial Breast DCE-MRIs to Predict Pathological Complete Response to Neoadjuvant Chemotherapy.

Authors:  Raffaella Massafra; Maria Colomba Comes; Samantha Bove; Vittorio Didonna; Gianluca Gatta; Francesco Giotta; Annarita Fanizzi; Daniele La Forgia; Agnese Latorre; Maria Irene Pastena; Domenico Pomarico; Lucia Rinaldi; Pasquale Tamborra; Alfredo Zito; Vito Lorusso; Angelo Virgilio Paradiso
Journal:  J Pers Med       Date:  2022-06-10

7.  Discriminating low-grade ductal carcinoma in situ (DCIS) from non-low-grade DCIS or DCIS upgraded to invasive carcinoma: effective texture features on ultrafast dynamic contrast-enhanced magnetic resonance imaging.

Authors:  Naoko Mori; Hiroyuki Abe; Shunji Mugikura; Minoru Miyashita; Yu Mori; Yo Oguma; Minami Hirasawa; Satoko Sato; Kei Takase
Journal:  Breast Cancer       Date:  2021-04-26       Impact factor: 4.239

8.  Radiomic machine learning for predicting prognostic biomarkers and molecular subtypes of breast cancer using tumor heterogeneity and angiogenesis properties on MRI.

Authors:  Ji Young Lee; Kwang-Sig Lee; Bo Kyoung Seo; Kyu Ran Cho; Ok Hee Woo; Sung Eun Song; Eun-Kyung Kim; Hye Yoon Lee; Jung Sun Kim; Jaehyung Cha
Journal:  Eur Radiol       Date:  2021-07-05       Impact factor: 5.315

9.  Early prediction of neoadjuvant chemotherapy response by exploiting a transfer learning approach on breast DCE-MRIs.

Authors:  Maria Colomba Comes; Annarita Fanizzi; Samantha Bove; Vittorio Didonna; Sergio Diotaiuti; Daniele La Forgia; Agnese Latorre; Eugenio Martinelli; Arianna Mencattini; Annalisa Nardone; Angelo Virgilio Paradiso; Cosmo Maurizio Ressa; Pasquale Tamborra; Vito Lorusso; Raffaella Massafra
Journal:  Sci Rep       Date:  2021-07-08       Impact factor: 4.379

10.  Quantitative Comparison of Prone and Supine PERCIST Measurements in Breast Cancer.

Authors:  Jennifer G Whisenant; Jason M Williams; Hakmook Kang; Lori R Arlinghaus; Richard G Abramson; Vandana G Abramson; Kareem Fakhoury; A Bapsi Chakravarthy; Thomas E Yankeelov
Journal:  Tomography       Date:  2020-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.